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Abstract

Central line-associated bloodstream infections (CLABSI) are a rising problem in the
critical care setting in the United States. According to Flogren et al. (2007), "an estimated
248,000 bloodstream infections occur in hospitals across the United States each year, and a
significant amount of these infections are associated with the use of a central venous catheter"
(p.160). The Center for Disease Control and Prevention (CDC) defines a CLABSI as "recovery
of a pathogen from blood culture (a single blood culture for organisms not commonly present on
the skin and two or more blood cultures for organisms commonly present on the skin) in a
patient who had a central line at the time of infection or within the 48 hours before the
development of infection" ("Vital Signs: Central Line-Associated Blood Stream Infections—
United States, 2001, 2008, and 2009," 2011, p. 447). After forty-eight hours, the development of
a CLABSI most often points to infection attributed to central line placement or maintenance.
The U.S. Department of Health and Human Services noted CLABSIs as a significant
concern and, in 2009, set a national goal for a 50% reduction in CLABSIs by 2013 (Wise et al.,
2013). Since then, however, hospital systems across the United States have been challenged with
meeting this goal. This project aims to improve the efficacy of the CLABSI bundle currently
used in the critical care setting by implementing nursing interventions supported by evidencebased practice that will help prevent the incidence of CLABSI in the acute care patient
population.
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Chapter I
Significance and Problem
Central Venous Catheters (CVCs) are necessary for the critical care setting as they
deliver lifesaving medications and provide hemodynamic monitoring. However, the longer
CVCs are in use, the higher the potential for exposure to central line-associated bloodstream
infections (CLABSIs), and sepsis development increases significantly. Consequently, CLABSIs
also have extraordinary costs ranging from $960 million to $18.2 billion annually (Benenson et
al., 2020). The Centers of Medicare & Medicaid Services (CMS) will reduce overall
reimbursements for hospital-acquired infections (HAIs), including CLABSIs, through the payfor-performance legislation (Deutsch, 2008). At the core of the pay-for-performance legislation
is a belief that is holding providers accountable for poor patient outcomes, encouraging providers
to improve the quality of the care they provide, and saving healthcare dollars (Deutsch, 2018).
Implementing the most effective bundle for CLABSI to reduce HAIs is imperative in decreasing
morbidity and mortality in the critical care unit. A CLABSI prevention continuous quality
improvement (CQI) initiative was started early in 2019 at the healthcare organization by
implementing chlorhexidine central line dressing kits with all central lines, which failed to bring
any meaningful improvement. The project failed because there was no articulated synergy
around the new processes and no clear communication regarding the new protocols. This project
will update the current CLABSI bundle used in the intensive care unit (ICU). The improved
CLABSI bundle components introduced by Zingg et al. (2014) include educating staff on
CLABSI prevention, implementing a CLABSI checklist, performing effective handwashing
techniques, utilizing chlorhexidine bath cloths and dressings, and developing a central line
surveillance program to evaluate maintenance and the ongoing indications for continued central
1

line use. This project will focus on reducing CLABSIs in the ICU, a patient safety issue that will
improve the quality of care provided in the critical care unit.
Purpose Statement
The purpose of this Doctor of Nursing Practice (DNP) project is to implement a
multidisciplinary CLABSI bundle introduced by Zingg et al. using a continuous quality
improvement framework to achieve a CLABSI Standardized Infection Rate (SIR) of 1.57,
a 10% reduction by December 31, 2021. Based on the literature and the CLABSI bundle
introduced by Zingg et al., the student researcher believes that improving the current CLABSI
bundle protocol will elicit an improvement in the overall quality of care for patients and a
reduction in CLABSIs in the ICU.
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Chapter II
Literature Review
In developing a literature review strategy, a systematic search to identify central
line-associated bloodstream infection (CLABSI) prevention studies were performed using a
narrative review process. PubMed, Cochrane, CINAHL, and Medline were the databases used in
this search. The keywords used were "central line-associated bloodstream infections,"
"CLABSI," "preventing health-care-associated infections," and "catheter-related bloodstream
prevention bundles." The search criteria returned over twenty-six thousand researchable articles.
The inclusion criteria used for the DNP project began with the search results for those addressing
CLABSI, prevention of CLABSI, and outcome comparisons with different elements of CLABSI
bundles. Of the articles returned in the search, countless seminal articles were identified.
Limiters and filters were used to decrease the pool of results to specifically meet the DNP project
goals. Additionally, gray literature, such as CLABSI guidelines from the CDC, NHSN, and the
Joint Commission, was reviewed to determine best practices determined by these national
organizations. Healthcare organizations have initiated extensive efforts to preclude CLABSI
through the use of evidence-based guidelines, and this action has led to statistically significant
decreases in CLABSI rates (Gilmartin et al., 2016).
According to Royer (2018), the most common risk factors for CLABSIs are a lack of
protocol reflecting evidence-based practice during central line insertion, colonization at the
central line site, choosing the femoral vein for line designation over the use of the subclavian
vein, prolonged use of the central line once placed, and lack of appropriate care of the central
line after placement.
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CLABSI Prevention
Zingg et al. (2014) suggest that clinically relevant hospital-wide CLABSI reductions
were reached with a comprehensive multidisciplinary team approach. The Zingg bundle included
an in-depth review of existing protocols regarding central line insertions and care after central
line placement, a detailed checklist, an e-learning module was created to educate physicians and
nurses on appropriate central line insertion techniques, and a central line surveillance program.
This randomized control study reported an 84% reduction in CLABSI in the intensive care unit
(ICU) over five years at a nineteen-hundred and eight-bed primary and tertiary care facility.
Education
A CLABSI bundle is a structured way of improving patient care and outcomes. The
CLABSI bundle compiles evidence-based practices that are critical elements of care to provide
an organized method of enhancing and surveilling the delivery of clinical care practices (Myatra,
2019). The importance of bundle education with each element is critical in ensuring all care steps
are delivered to support this patient safety initiative.
The ICU nurses will be educated on hand hygiene, maximal barrier precautions by
wearing a protective mask, sterile gown, and gloves during central line insertions, chlorhexidine
skin antisepsis, catheter site selection, performing daily central line rounds with the intent of
determining central line necessity. This training will be rigorous and provided in both didactic
and practical form by the ICU team, infection control nurses, and facility educators. CLABSI
training will also transpire daily each shift during the safety huddle. Safety huddles are required
on each shift, and it is an effective way of communicating, sharing information, reviewing
quality-related performance, improving quality and patient safety.
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Hygiene
Preventing the transmission of germs through hand contact is a critical component of the
CLABSI bundle. Effective hand hygiene prevents the transmission of pathogens and has been a
noted element of every evidence-based CLABSI bundle (Myatra, 2019). To effectively minimize
the risk of CLABSI associated with healthcare providers' hand hygiene, the ICU staff must be
educated on the transmission of pathogens. This education should be based on five elements:
"before touching the patient, before performing any clean or aseptic procedure, after exposure to
body fluid, after touching the patient, and after touching the patient's surroundings" (WHO,
2009). According to the World Health Organization (2009), "Five Moments for Hand Hygiene
should be utilized as an evidence-based approach in educating health care providers regarding
the prevention of hospital-acquired infections (HAIs)."
Chlorhexidine
Chlorhexidine (CHG) is a broad-spectrum biocide and has shown remarkable efficacy in
decreasing the incidence of CLABSI in the ICU (Royer, 2010). Chlorhexidine has been proven
effective against a broad range of bacteria and fungi, and its properties can kill most bacteria
within thirty seconds of contact (Myatra, 2019). From their systematic review, Lewis et al.
(2019) concluded the need for chlorhexidine bathing or chlorhexidine dressings as a
recommendation for all CLABSI bundles. Moreover, using chlorhexidine with patients in the
ICU during bathing of part of or all of the body will potentially provide a protective coating to
further reduce the risk of hospital-acquired infections, such as CLABSI.
CLABSI Checklist
Introducing the CDCs CLABSI Checklist will improve compliance with sterility
standards for central line placement in the ICU. Checklists have been used in numerous settings
5

and have successfully decreased the incidence of CLABSI (Wichmann et al., 2018). When the
organization implemented the current CLABSI bundle, they did not include the CDC's CLABSI
prevention checklist. The CDC CLABSI checklist will provide guidance in following proper
central line catheter insertions, handling and maintaining central lines appropriately, removing
central lines, and providing staff with the education they need to reduce the incidence of
infections related to CLABSI in the ICU. In preparation for this project, the CDC CLABSI
Checklist was added to the current CLABSI bundle as suggested by Zingg. The Director of
Infection Prevention (DIP) will implement the CDC CLABSI checklist as an additional tool to
improve CLABSI bundle compliance as part of this project. During the preparation phase of this
project, the DIP will educate the ICU nurses on the improved bundle components and the
intended use of the CDC CLABSI Checklist.
Surveillance
The importance of central line care and surveillance in preventing CLABSI is well
documented in the literature (Grigonis et al., 2016). It is essential to develop a central line
surveillance program to perform a daily evaluation of any current central lines, and any central
line that is not being used for treatment should be removed immediately (Grigonis et al., 2016).
The hospitals' infection prevention nurses will conduct central line surveillance on every
patient in the ICU with a central line catheter. The infection prevention nurses will provide
weekly feedback on hand hygiene performance and infections. They will provide detailed
information on CVC type, insertion site, and dwell time. The organization's comprehensive
infection control program will also include daily central catheter line rounds in which the DIP
and ICU Director will review the necessity of central lines, daily maintenance, and timely
removal.
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Bundle Compliance
All components of the CLABSI bundle will be monitored closely by the DNP project
team for compliance. The compliance program will include staff awareness, re-education, and
proper adherence to all CLABSI bundle components. Any non-compliance with any portion of
the CLABSI bundle will be documented and shared with the ICU team for immediate correction.
It is essential to understand that if there is a failure of adherence to any one component of the
CLABSI bundle, it will make the bundle compliance zero (Royer, 2010).
Southworth et al. (2012) noted that by monitoring compliance of bundle elements of hand
hygiene, chlorhexidine skin disinfection, barrier precautions during catheter insertion, catheter
hub, or connector disinfection, education of nurses and physicians, daily review of central line
necessity, dedicated central line team, and standardized central line catheter insertion cart they
had decreased and maintained a zero CLABSI rate and decreased their overall morbidity and
mortality rates over five years.
Summary. In summarizing the literature review, the evidence reviewed for this DNP
project strongly suggests that implementing a CLABSI bundle with patients in the critical care
arena will help decrease the incidence of infection in their patients. Expanding the health care
organization's current CLABSI bundle to include the CDCs Checklist to prevent central lineassociated infections will help them ensure staff understands all the elements they need to
perform in this initiative. The studies reviewed for this project have conclusively provided
evidence that prevention of infection is possible. CLABSIs are among the most frequent
healthcare-associated infections that the healthcare organization has been challenged to
overcome. Implementing an effective CLABSI bundle is imperative in keeping patients free of
infection.
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Needs Assessment
In early 2018, the healthcare organization initiated a detailed plan to eliminate the
incidence of CLABSI. The hospital performed several Failure Mode and Effects Analyses
(FMEAs), which showed elements of care that needed immediate attention, which led to the
elimination of the swab caps and the bio-patch. The organization introduced Prevantics cloths for
skin preparation and scrubbing the hub of all catheters before accessing the central line.
Although the organization made incremental improvements in the past, they were still not where
they needed to be with this metric in providing safe, quality patient care.
According to Thompson (2011), "the Centers for Disease Control and Prevention
Department of the National Healthcare Safety Network (NHSN) is the nation's most widely used
healthcare-associated infection tracking system." It states that the SIR for an acute care facility
should be less than 0.90. However, the facility remains above or equal to 1.755. The
Standardized Utilization Ratio (SUR) measures device utilization over time. The SUR for the
facility remains higher than the benchmark set forth by NHSN, at 0.926. The current state of
their SIR is a significant patient safety concern for their organization and the community they
serve. Patients deserve to be treated in a manner where they are not at risk for developing a
hospital-acquired infection. This project will promote a shift in the organization's culture to
update its protocols to reduce CLABSIs and other hospital-acquired infections.
Population of Interest
The population identified for this DNP project will include any patient evaluated on
admission to the ICU with the presence of a central line or any patient located in the ICU with
an order for central line placement during the implementation phase of this project. In order to
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accomplish the goals of this project, the nursing staff that provides direct patient care in the ICU
will be educated on the components of the improved CLABSI bundle, CLABSI prevention
measures, the CDC CLABSI Prevention Checklist, and the CLABSI SIR.
Project Sponsor and Key Stakeholders
The sponsor for this project is the Director of Infection Prevention (DIP). The DIP will
collaborate with the student researcher and author of this manuscript to ensure that the mission,
goal & objectives of this project plan are successful. It is important to note that this project's
primary stakeholders and recipients are the ICU patients. The ICU patients are followed by the
registered nurses (RNs), intensivists, and the hospital's executive team.
Many efforts have been made to eliminate CLABSIs by internal and external
stakeholders across the nation due to the Centers for Medicare & Medicaid Services value-based
programs. The goal of the value-based programs is to promote a higher quality of care and a
positive overall outcome for patients (Thompson, 2011). Reducing CLABSIs in the ICU will
improve patient care and the hospital's patient safety score rating.
Team Composition
The team composition for this project consists of the DIP, ICU Director, charge nurses,
nurses, and ICU intensivists. The team leader determined for this project was the ICU Director.
The ICU Director will manage the project goals and communicate the objectives to the team in
collaboration with the DIP.
The Chief ICU Intensivist will work as the physician champion for this project and
ensure alignment and buy-in with fellow ICU intensivists. The goal for the intensivist will be to
ensure they are following the guidelines of the evidence-based CLABSI bundle defined by Zingg
et al.
9

Scope of the Project
This project's scope is to improve the current CLABSI bundle utilized by the hospital by
improving the CLABSI bundle as recommended by Zingg et al. The improvements to the
CLABSI bundle will be limited to the ICU. This quality improvement project will also include
educating and training the nurses regarding decreasing CLABSIs in the ICU. The acute care
facility will not utilize this quality improvement project in the facility with any other clinical
areas.
Mission, Goals, and Objectives
Mission
The mission of this project is to update the healthcare organization's current CLABSI
bundle with a nurse-driven evidence-based protocol that will result in a sustained reduction in the
incidence of CLABSIs in the ICU.
Goal
This DNP project aims to improve the current CLABSI bundle with evidence-based
components that will reduce or eliminate the incidence of CLABSI in the healthcare entity's ICU.
An additional goal for this project will be to educate the ICU team on preventing CLABSI and
the improvements to the CLABSI bundle.
Objectives
The objectives for this project will be introduced as process and outcome measures. The
outcome measures goal for this project will be to:
1.

Reach a 10% reduction in CLABSIs in ICUs by the 4th Quarter of 2021.

The overall process measures goal for this project will be to:
10

1.
2.
3.

95% of the ICU team will have completed training on the updated CLABSI bundle by
October 1, 2021
Reach 100% compliance with the CDC CLABSI Prevention Checklist by October 1,
2021
Prepare monthly progress reports on the CLABSI SIR to guide adjustments in the project

11

Chapter III
Theoretical Underpinnings of the Project
The theoretical framework for this DNP project provides the logic behind the
interrelationships of elements critical to successful implementation, explanation, and
understanding of sustained change. The theoretical framework used for this project is Kurt
Lewin's change theory. Lewin's Model for Change Management addresses care transformation
in clinical practice. According to Tracy (2021), "Lewin's theory proposes that individuals and
groups are influenced by restraining forces, or obstacles that counter driving forces aimed at
keeping the status quo, and driving forces, or positive forces for change that push in the direction
that causes change to happen"(p. 24). Lewin's change theory was selected for this project
because of its ease of use, and it also allows the team to advance through each stage with clear
identification of achievement. In Lewin's change model, the first premise is initiated by the
willingness and readiness for change. The catalyst for change is grounded on a force field of
driving and restraining forces (Tracy, 2020). To bring about change, the force field must be
transformed so that the driving forces are stronger than the restraining forces (Tracy, 2020). The
team must realize these driving factors before the initiation of change.
The first step in Lewin's change theory is known as "unfreezing," which assumes that
current beliefs, expectations, and norms can be transitioned into new ideas and behaviors. This is
the most challenging phase in most organizations. Change of old beliefs, habits, and clinical
practices is difficult. Although change is inevitable and an essential ingredient for growth, the
healthcare organization has stagnated and requires new knowledge and strategies for this
significant patient safety issue. In this phase, the organization will "unfreeze" current practice by
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reviewing the ICUs' current state, communicating the need for change, and creating the
momentum for the change required to meet their goal of reducing CLABSIs.
The second step in Lewin's change theory is the change itself. By re-educating the ICU
team changing attitudes and clinical processes, the healthcare organization will redefine its
current CLABSI guidelines and practices. During this phase, they will need to be clear in
communicating the vision for change, benefits for their patients with this change, and the
necessary steps of the change process. This is also the stage where their leaders will
promote, empower action, and encourage the ICU team to get involved by creating a safe
environment for their patients.
The last step in Lewin's change theory is known as the "refreezing" phase. This phase
transforms the newly implemented change into a sustained practice aligned with a culture of
safety. This phase is outside the scope of this project because the project is time-limited to four
months.
Lewin's change theory will offer a framework to successfully assist this project in
initiating, evaluating, and solidifying the necessary changes to reduce CLABSIs in the ICUs.

13

Chapter IV
Project and Evaluation Plan
This chapter will describe the scope and evaluation plan for this DNP project. This will
include the project setting, population of interest, process measurement and instruments,
timeline, and evaluation plan.
Project proposal
Setting. The project will transpire in an acute care hospital's adult intensive care unit
(ICU). The hospital is classified as a 293-bed adult acute care facility located in a lowsocioeconomic community in Las Vegas, Nevada. The critical care department is comprised of
three units, the intensive care unit, the cardiac care unit, and the medical intensive care unit.
Population of Interest. The population of interest identified for this project will be all
adult patients admitted to the intensive care unit (ICU) with a central line or any patient in the
ICU with an order for central line placement. This project will also focus on educating and
training the ICU nurses, physicians, and other clinical care team members who will provide
direct patient care to patients in the ICUs with central lines.
Project Tasks. Project tasks consist of:
Summer, 2021
•

Submit DNP project to IRB for exemption

•

Update the existing Central Line-Associated Bloodstream Infection (CLABSI) bundle
protocol to the version used by Zingg et al.

•

Develop an educational module for the ICU teams through the eLearning
Management System (LMS)
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August 2021
•

Begin ICU team education with didactic and e-learning training modules

September 2021
•

Implement the CDCs CLABSI Prevention Checklist

•

Monitor progress on completion of training – make adjustments as necessary

•

Obtain baseline SIR data (August 2021) from the Director of Infection Prevention
(DIP)

October – December 2021
•

Monitor progress on SIR data; make adjustments as necessary

•

Monitor compliance with the CDC Checklist for Prevention of CLABSI by audits

Measures of Evaluation
CLABSI Bundle Education and Training
This DNP project initiated CLABSI bundle education and training sessions with the ICU
nurses through the facilities eLearning Management System (LMS). The CLABSI training
modules through LMS included 40–60-minute informative sessions regarding the CLABSI
Bundle, CLABSI Prevention training (Appendix D), the Checklist for Prevention of the
Prevention of Central Line-Associated Bloodstream Infections (Appendix C), the five moments
for hand hygiene (Appendix J), the central line necessity tracking tool (Appendix G), and
CLABSI prevention training (Appendix D). The LMS education will be managed by the
facilities Nurse Educator and the DIP. The nurse participants will be given, "Does my patient
have an Infection?" (Appendix E) that provides the general signs and symptoms of CLABSI, and
they will receive training on bathing patients with chlorhexidine bath cloths (Appendix F). At the
15

end of the CLABSI education and training, each nurse participant will sign the Central Line
Maintenance and Blood Cultures Attestation (Appendix H) that attests that they understand the
importance of implementing these processes into their daily practices and understand the
expectations outlined in this CLABSI bundle education and training session. Once the attestation
is electronically signed at the conclusion of the education session in LMS, the completion of the
required education for the DNP project will be calculated as compliant. The CLABSI bundle
education and training represent the percent of the ICU nurses who completed the education
module. The facilities nurse educator will audit the education completion daily using the LMS
compliance software program and report the percent of compliance to the DNP student
researcher monthly.
In addition to the CLABSI education and training sessions, the nurse participants will
also be provided handouts by the DIP on the appropriate use of the hand hygiene observation
tool (Appendix I).
CDC CLABSI Prevention Checklist
As part of the CDC CLABSI Prevention Checklist, the DIP, ICU Director, and Charge
Nurse are responsible for performing daily surveillance rounding on patients with central lines as
part of standard protocol. The CLABSI surveillance rounding will include a full assessment of
the central-line dressing, review of any signs or symptoms of central-line site infections,
compliance with central-line dressing changes, ensuring the use of CHG as a bathing agent, and
cleaning the skin with CHG before any peripheral blood draws are performed. The ICU Director
and ICU Intensivists are also responsible for performing daily central line necessity rounds to
ensure clear indications for continuing the central line use met indication criteria. The DIP
reported the components of CLABSI surveillance with the total number of completed CDC
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CLABSI Checklist compliance data. For the purposes of this DNP project, the result of
surveillance will be reported to the student researcher as the proportion of the number of
completed checklists weekly.
The CDC CLABSI Prevention Checklist will be available to the ICU nurses through the
facility's electric health records (EHR) and should be completed with any patients identified as
having a central line or with an order for central line placement. The DIP will audit ten charts per
day to measure the completion of the CLABSI checklist. Measurement of CLABSI checklist
compliance will conclude when the goal of 100% compliance is reached by October 2021.
Standardized Infection Ratio (SIR)
The SIR will track the rate of CLABSIs. This measure is defined by the CDC/NHSN as the
number calculated by multiplying the national CLABSI rate by the observed number of central
line days in that specific location (Thompson, 2011). It is essential to define inclusion and
exclusion criteria for central lines in developing the project to better manage the healthcare
organization's CLABSI outcome data. The inclusion criteria for central lines are that the central
line must be present on admission to the ICU, or order for central line placement was obtained
during the patient's stay in the ICU. The exclusion criteria for central lines will be the use of a
midline catheter.
The DIP will calculate the SIR from the NHSN database monthly as part of the standard
protocol. The DIP will provide the monthly SIR to the student researcher by Monday the
following week.
Hand Hygiene Observation Audits
The department is required to perform two-hundred hand hygiene observations monthly
as part of standard protocol. Hand hygiene observations will be conducted daily by the DIP, ICU
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Director, and assigned nurses. The DIP will track and collect the hand hygiene observation audits
and calculate the percentage of compliance with nurses while entering and exiting patient rooms
and before patient care. The DIP will provide monthly hand hygiene compliance percentages to
the student researcher at the end of every month during the project implementation phase.
Timeline
The timeline projected for this project will extend from October 2021 through December
2021. A comprehensive timeline with the associated project tasks for this project is included in
the appendices.
Institutional Review Board Approval
This project aims to improve the CLABSI bundle currently utilized at the facility to
decrease the incidence of CLABSI in the ICU by using recommendations from Zingg et al. The
project includes educating the staff of the ICU and intensivists. This project is designated a
quality improvement (Q.I.) project and does not include human subjects. Due to the nature of this
project, the UNLV Biomedical IRB determined that this project was excluded, and IRB would
not be required.
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Chapter V
Summary of Implementation and Results
Problem and Purpose of the Project
Central line-associated bloodstream infections (CLABSIs) have been a significant patient
safety concern for patients in acute care hospitals and, more specifically, intensive care unit
(ICU) settings (Thompson, 2011). This project decreased the incidence of CLABSI by greater
than the goal of 10% by improving the current CLABSI bundle by implementing additional
evidence-based strategies suggested by Zingg et al.
The facilities executive teams' interest in the project stems from wanting to improve the
overall care that the hospital provides to its patients by decreasing HAIs, morbidity, and
mortality in the critical care setting. Decreasing CLABSIs in ICU will also reduce the financial
penalties the hospital has faced over the last three years due to hospital-acquired conditions
(HACs).
CLABSI Bundle Improvements
As the literature suggests, multiple strategies may be implemented to prevent CLABSIs
in the ICU (Thompson, 2011). However, there must be a commitment from the healthcare
leadership team to educate nurses and providers on the importance of preventing CLABSIs and
how they can contribute to improving this metric and overall patient safety. The CLABSI
protocol update began in November 2020 with a literature search and designing improvements to
the current CLABSI bundle. The improved CLABSI bundle was deployed in October 2021 under
the auspices of the DNP student researcher. The hospital DNP project team included the
Executive Leadership Team, Director of Infection Prevention (DIP), Nurse Educator, ICU
Director, ICU Manager, Risk Director, ICU Charge Nurses, and Intensivists. The DNP project
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team attended an initial meeting to review the timeline, outline their roles, and discuss the
project. Introductions to the DNP project team and their positions were outlined and discussed in
detail. The ICU Director was determined the team leader. The DIP would manage, communicate,
and distribute CLABSI data to the team and monitor the SIR, and the ICU intensivist would
ensure compliance with the project from a provider standpoint. Communication of the intent of
this project aligned with the goals and objectives set forth by the facilities executive team as it
related to decreasing HAIs, which was essential in aligning the rest of the organization's team
members.
Project Risks
The DNP Project team identified two risks to this project. The first risk was related to the
education compliance requirement for staff in the ICU. The project requires that 95% of the ICU
team complete the updated CLABSI bundle training by October 2021. However, nurse turnover
slowed the progress of educating the staff during the initial stages of the education program. The
DNP Project team decided that it was integral to provide the CLABSI training weekly to
accommodate the rapid turnover of nurses and keep the project on track. Notification of the
necessary learning modules for the CLABSI training was sent out weekly to all active nurses of
the ICU with the completion deadline date. The Director of Infection Prevention (DIP) and ICU
Director ensured continuous management and follow-up with the CLABSI education despite the
nursing turnover.
The second risk to this project was the critical nursing shortage in the ICU. Nurse
turnover rates related to the COVID-19 pandemic significantly impacted the hospital's operations
and, more specifically, the ICU. This risk was mitigated by employing travel nurses that would
work in temporary staffing positions in the ICU for approximately three months or until the
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department met safe staffing ratios by hiring and retaining internal staff. Increased education and
management of staff were essential to ensure appropriate education and expectations of this
project were clearly expressed and understood through the rapid transition of travel nurses
needed to support hospital operations. The DIP and the ICU Director provided additional training
and education regarding the prevention of CLABSI through in-services and individual training.
Due to the staffing shortage, the DNP Project team decided that it would be necessary to keep the
education and training open during the entire project period. Leaving the education open
throughout the project led to the CLABSI education compliance rate reaching a 100%
compliance goal, even though the initial timeline for completing education and training was
October 2021.
Staff Training
The project started with educating the ICU nurses and intensivists on CLABSI
prevention. In addition to the CLABSI bundle education and training, the DIP educated the
nurses on hand hygiene, chlorhexidine skin antisepsis, clinical manifestations of infection at the
central line site, chlorhexidine central line dressings, and maintenance, and the expected use and
compliance of the CDC CLABSI Checklist. As stated previously, the education program was
implemented according to the project plan timeline. The CLABSI education program did not
reach the benchmark of 100% compliance by the goal date of October 2021. The DNP Project
team increased the frequency of education to improve education compliance with the ICU nurses
and successfully improved compliance. The DIP and ICU Director tracked and disseminated
education compliance weekly to the student researcher and the DNP project team.
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Monitoring of the Project
The project started with educating the ICU nurses and intensivists on CLABSI
prevention. In addition to the CLABSI bundle education and training, the DIP educated the
nurses on hand hygiene, chlorhexidine skin antisepsis, clinical manifestations of infection at the
central line site, chlorhexidine central line dressings, and maintenance, and the expected use and
compliance of the CDC CLABSI Checklist. The DIP and ICU Director tracked and disseminated
education compliance weekly to the student researcher and the DNP project team. CLABSI
education compliance was monitored very closely during the first weeks of this project, and
monthly once 100% of the nurses actively working in the ICU met the education requirement for
four weeks.
This document's student researcher and author monitored the project throughout the
implementation phase by meeting weekly with the DNP Project team. The student researcher
coordinated and collaborated with the acute care facility's nurse educator initially to ensure
alignment with the educational goals and objectives of the project. Monthly monitoring of the
CLABSI SIR data was necessary to ensure the team met the overall goals and objectives and that
the project was trending in a positive direction. The student researcher held weekly meetings
with the DNP project team to review data and identify solutions to barriers. The student
researcher rounded in the ICU daily and had formal and informal discussions with the ICU
Director and staff to stay engaged with the project and process. As previously discussed, the ICU
Director identified nurse turnover as a potential challenge during the first two weeks of
implementing the project. The student researcher, DIP, and ICU Director collaborated and
provided effective strategies to ensure the nurse educator offered additional training to the staff
to support the rapid turnover of ICU nurses.
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The student researcher spent numerous hours with the DIP and ICU Director in reviewing
CLABSI education and bundle compliance, CDC CLABSI checklist element compliance,
central-line surveillance, handwashing observations audits, and CLABSI SIR data.
Data Collection
During the first month of the project implementation, due to nursing shortages related to
the COVID pandemic, the nurses were challenged with completing the CLABSI educational
competencies. The ICU team leader implemented additional communication to ensure nurse
compliance. As shown in Figure 1, CLABSI education compliance in October 2021 ended at
78%, and both November and December of 2021 ended at the goal, which was 100%
compliance.

Figure 1
CLABSI LMS RN Education Compliance
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Table 1
Number of Nurses Educated by Month
October 2021

November 2021

December 2021

58

32
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The DIP collected the CDC CLABSI Checklist daily and measured the compliance of the
nurses completing the checklist with each patient identified as having a central line. The DIP
audited the checklist elements and reported the checklist compliance weekly to the DNP project
team. As referenced in Figure 2, the checklist compliance was 58% in October and 100% in both
November 2021 and December 2021. The DIP and DNP Project team discussed the checklist
non-compliance and initiated additional nurse training with the DIP and ICU Director in late
October 2021. The DIP also performed daily auditing and reconciliation of patients in the ICU
identified as having a central line. Auditing compliance by shift and reconciliation of patients by
the DIP ensured 100% checklist compliance.

24

Figure 2
CDC CLABSI Checklist Compliance
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As shown in Figure 3, the nurses were observed randomly entering and exiting patient
rooms throughout the ICU during CLABSI surveillance rounds. Hand hygiene compliance
remained above the 90th percentile pre-and post-project implementation, a benchmark set by the
facility.
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Figure 3
ICU Hand Hygiene Compliance Pre-Post Project Implementation
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The DIP monitored, tracked, and disseminated the CLABSI SIR data during the weekly
DNP project meetings. Monthly monitoring of the CLABSI SIR data was necessary to ensure the
team met the overall goals and objectives and that the project was trending in a positive
direction. As shown in Table 1, the DIP reported that during the pre-project period from January
2021 to September 2021, the facility reported fifteen CLABSIs to NHSN with a SIR of 1.755 per
1,000 catheter days and a SIR p-value of 0.043 and CLABSI SUR of 0.926. The resulting SIR pvalue of 0.043 demonstrated a statistical significance between the observed number of actual
infections and the expected number of infections significantly higher than what was predicted by
the NHSN methodology.
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Table 2
ICU CLABSI Rate Pre-Project Implementation

Reporting
Metric

CLABSI
Count

Number
Expected

SUR

SIR

SIR pvalue

Lower CI

Upper CI

CLABSIICU

15

8.55

0.926

1.755

0.043

1.020

2.830

As shown in Figure 4, the monthly CLABSI rate totaled fifteen, and the central line SUR
was consistently over the national standard. The DIP monitored the SUR as part of the CLABSI
SIR data to monitor and compare the widespread use of central line device utilization in the ICU.

Figure 4
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0

0

0

Giving Meaning to the Project
Results
This project met the objective of reducing the CLABSI SIR by 10%. The organization
calculated the total cost avoidance for CLABSIs due to this DNP project during the
implementation phase, and it was calculated at $266,744.92, which was significant. The cost
avoidance was estimated by calculating CLABSI numbers pre-and post-project implementation
by the facility.
Initiating a quality improvement project in the middle of a worldwide pandemic was
challenging in almost every way, and the nurse turnover rate in the department was at an all-time
high. Educating the ICU nurses on the importance of CLABSI prevention was paramount during
the initial stages of this project and throughout. However, this project did not meet the objective
of having 100% of the nurses trained by October 2021. The nursing shortage that ensued due to
the pandemic caused the DNP project team to think outside the facility's usual education practice
to a more flexible format. As exhibited by the DNP project team, this flexibility resulted in 100%
of the nursing compliance with the CLABSI education by the second month of the project's
initiation.
The rate of compliance with the CDC CLABSI checklist started similarly to the progress
of the CLABSI education during the project's initiation. Although the DNP project team did not
meet the goal of 100% compliance with the checklist within the first thirty days of the project, it
may not have been a realistic goal from the beginning. Implementing a new process was
challenging and demanded more time than the student researcher initially calculated. Lewin's
change theory suggests that changing current beliefs and norms is arguably the most challenging
phase of change for most organizations (Tracy, 2020). To implement the change desired in this
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project, the student researcher had to communicate why this project was essential to the facility
but, more importantly, the patient.
The control chart in Figure 5 represents the CLABSI SIR rates from the 4th Quarter of
2020 through the 4th Quarter of 2021. The data reflects that before the 4th Quarter of 2021, the
CLABSI rates were consistently over the NHSN National SIR benchmark, which elicited the
need for this project.
The DIP reported the CLABSI SIR data for the 34 bed ICU and noted 457 patients and
5,027 catheter days during the project implementation phase. The data for the post-project
implementation phase of October 2021 through December 2021, as displayed in Figure 5,
exhibits a decrease in the overall number of CLABSIs to zero and a significant reduction in the
SIR to zero per 1,000 catheter days. The reduction noted during the project period represented a
100% decrease in CLABSIs post-project implementation. A remarkable reduction of the
CLABSI SIR was noted during the 4th Quarter of 2021, which is concurrent with the initiation of
this project.
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Figure 5
ICU CLABSI Rate Comparison Pre-and Post-Project Implementation

Discussion
CLABSIs are among the most harmful hospital-acquired infections (HAIs), with an
estimated 10-25% mortality rate (Wichmann et al., 2018). Not only do CLABSIs place patients
at significant harm, but they are also costly to health care organizations due to decreased
reimbursement for the poor quality of care they provided and increased length of stay for patients
that develop CLABSIs. This project demonstrated a clear association between the
implementation of the contents of this project and the reduction of CLABSIs. At the beginning of
this project, the goal was to decrease CLABSIs by 10% in the ICU. In comparing the pre-andpost project implementation phase, there was an observed 100% reduction in the CLABSI SIR
that far exceeded the 10% reduction outlined as the goal of this project. Through the end of this
project, the ICU had established a CLABSI rate of zero. This project demonstrates that CLABSIs
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are preventable in the critical care setting and supports the Zingg et al. study, which suggests
90% of CLABSIs are preventable (Zing et al., 2014).
This project significantly decreased the incidence of CLABSI in the ICU. The facility
utilized a CLABSI bundle that required improvements with components that were grounded in
evidence-based practices. Educating the staff regarding evidence-based guidelines in the
prevention of CLABSI was critical. Nurses are on the frontline of CLABSI control and
prevention, and it was vital to have them engaged with this project and process.
As prognosticated by Lewin's change theory, the impetus for change must be driven by
motivation and the need for change (Tracey, 2020). During the initial stages of this project, there
was a fair amount of internal and external restraining forces. However, the ICU team was
educated on the benefits of following evidence-based practices to decrease CLABSIs in the ICU
and the positive outcome this project would have on patients. Collaboration and commitment of
the ICU team assisted this project in overcoming any barriers in implementing the improved
CLABSI bundle components.
This project improved nursing practice and patients' overall care in the ICU. Moreover,
this project demonstrated that educating staff in CLABSI prevention, implementing evidencebased interventions, and CLABSI surveillance can significantly decrease CLABSI rates; in this
case, it led to a 100% reduction.
Moreover, this project did not have any upfront costs associated with implementation and
posed zero financial liability for the facility from a financial perspective.
Potential for Sustainability
This quality improvement project demonstrated that with diligence, collaboration, and a
plan decreasing CLABSIs to zero is possible. Utilizing an evidence-based central line bundle has
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been proven to decrease the incidence of CLABSI in hospital systems (Gilmartin et al., 2016).
Zingg's CLABSI bundle recommendations have proven to be valuable in reducing the incidence
of CLABSI in the ICU setting. The literature suggests that utilizing an evidence-based CLABSI
bundle is key to decreasing CLABSIs in the ICU. This project is proof that reducing harm is
possible.
It is in the best interest of the stakeholders to continue to utilize the improvements made
to the CLABSI bundle that were implemented with this project. Although there were staffing
challenges due to the COVID pandemic, the team was engaged throughout the project and was
committed to creating a safe environment for patients. This project assisted the ICU team in
developing and promoting an improved patient safety culture and evidence-based processes that
will reduce the rate of CLABSI in the ICU. The CLABSI bundle elements suggested by Zingg
are sustainable with the commitment of all stakeholders, and the journey to zero infections is
possible.
Dissemination of Results
Dissemination of the results of this project was shared continuously with the DNP project
team throughout the duration of the project. The project's final results were shared with the
quality improvement and executive teams on January 17, 2022. As a result of the success of this
project, the facility will be utilizing the CLABSI bundle improvements implemented in this
project to elicit the same success throughout the hospital. Additionally, the student researcher
will share the results of this project during an upcoming corporate quality improvement seminar
to share the CLABSI bundle improvements and assist other ICUs in reaching the same positive
outcomes. This project's findings and results have been scheduled to be distributed to the
organization's six other acute care hospitals during the second quarter of 2022 through their
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Medical Executive Committees for review and approval as a new CLABSI bundle protocol for
their hospitals. Additionally, the student researcher will disseminate this project at the 2022
Western Institute of Nursing (WIN) conference.
Conclusion
The Covid-19 pandemic has placed additional pressures on healthcare organizations to
decrease the incidence of infections and, more specifically, CLABSIs. Recent literature reports
that CLABSI rates have increased by 51% during the pandemic (Faki et al., 2021). This finding
emphasizes the significance of developing evidence-based strategies to decrease the incidence of
CLABSI and positive patient outcomes. Understanding the importance of the journey to zero
infections was essential for the team to gain trust and commitment in this endeavor.
In summary, this project successfully decreased the incidence of CLABSI in the ICU
setting by 100% during the project implementation phase, which was significantly greater than
the goal and expectations of this project. This project proves that an evidence-based CLABSI
bundle approach can decrease CLABSIs in the ICU. However, it takes all the stakeholders'
engagement, collaboration, and commitment to induce change and sustain it.

33

Appendix A – Institutional Review Board Approval
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Appendix B – Detailed Timeline
Detailed Timeline
Month/Year
September – October 2020

Project Tasks
Development of DNP Project Topic

November 2020

Review of the Literature & CLABSI Bundle Protocol

December 2020

Identification of DNP Nursing Chairperson, UNLV Faculty
Member, and Representative from the Graduate College

January

Finalized DNP UNLV Advisory Committee Members

March 2021

DNP Proposal Submitted to the UNLV Advisory Committee

April 2021

DNP Proposal Defense to the UNLV Advisory Committee
Members

April 2021

DNP Project Approval from the UNLV Advisory Committee
Members

June 2021

IRB Exempt Research Application Submitted

August 2021

IRB Notice of Exclusion from UNLV

August 2021

CLABSI Prevention Staff Education and Training Developed

September 2021
October 2021

DNP Project Introduction & Scope meeting with the DNP
Project and Hospital Executive Team
DNP Project Initiation

December 2022

DNP Project Conclusion

January 2022

Analysis of Project Data

February 2022

Synthesis of Data and Dissemination of DNP Project Results

March 2022

DNP Project Defense Completed and submitted to the UNLV
DNP Committee Members

March 2022

DNP Project Defense Presentation at UNLV
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Appendix C – Checklist for the Prevention of Central Line-Associated Bloodstream
Infections
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Appendix D – CLABSI Prevention Training
CLABSI Prevention Training
The goal is to minimize line utilization (PICC, central line)
• Always confirm the absolute necessity of central line placement
• Use a Midline instead of a PICC line whenever you can
• Pull lines as soon as no longer necessary
When lines are necessary, proper line maintenance is imperative (this includes PIVs!)
• If a patient has a CL and a PIV line and the pathogen gains access to the bloodstream via
the PIV, then is it STILL going to be a CLABSI!
Proper Line Maintenance
• 3M CHG gel dressing – fully adherent, date and initialed
• Prevantics – scrub the hub
• PIV dressings
• Daily CHG bath / Hibiclens bath for all patients with central lines/PICC lines
• Daily line assessment (integrity, continued use, and appropriate indication)
• Label and date all lines
• Change ALL POA dressings
• Remove ALL field stick PIVs within 24 hours of admission
• Patients with C.L.s should not also need a PIV
• Emergently placed femoral lines should be removed within 24 hours
Vascular Access Team/PICC Team
• When in doubt/have questions/need guidance…CALL THEM…they are a tremendous
resource and asset
• PICC Team should be consulted on all newly placed femoral lines
Infection Prevention Team
• Call us – do not hesitate!!
Disarm the Arms
• Before every blood culture draw - 1 wipe for each arm shoulder to fingertip!
• Proper decontamination of the skin is essential to avoid contaminated blood cultures. A
contaminated specimen can result in a CLABSI and/or a delay in the redraw, which can
land us in a CLABSI window period
Timing on obtaining blood cultures is critical!
• In order to avoid being in a CLABSI window, blood cultures must be collected 2 calendar
days from either line access or line placement (where access/placement is considered
calendar day 1)
• Do NOT access lines that don't need to be accessed (i.e., Ports)
• DO NOT collect blood cultures off of a line UNLESS the Physician suspects the line is
the source of infection and in that case the doctor's order must specifically request a line
draw (if multiple lines are present draw from the line, they suspect is the infected line)
• Watch your cultures – as the nurse you are responsible for the tests being performed
during your shifts
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Know what clinical indications may prompt you to obtain an order for blood cultures
• Timing is key!
• Refer to "Indications to Perform Blood or Urine Cultures on Admission" handout
• We have 2 calendar days from the moment a patient hits an inpatient floor (which
may be sooner than the admit date) with a line in place, accessed, or after any newly
placed line, to identify a bloodstream infection
Do not be afraid to question a blood culture order
• Orders may sometimes be inappropriate
• Advocate for your patient
• Escalate all new blood culture orders after calendar day 2 too your Clinical
Supervisor/Director
Consider All Other Sources of Infection
• Wound cultures, pneumonia, primary source of infection elsewhere
• Where did the patient come from (i.e., risk factors, recent history of infections during
previous encounters)?
Hand Hygiene
• Not just upon room entry and exit. Never move from contaminated to clean. Comply with
all in-room hand hygiene opportunities
• Ensure proper patient hand hygiene! Use the Sani-hands
High Touch Surfaces
• Should be wiping down high touch surfaces once a shift. It is not the sole responsibility
of EVS!
• Wipe down WOWs and portable equipment between patients
Think DISCHARGE
• Be proactive in this process – the longer a patient is here, the greater the risk we run for
an HAI especially when there are lines in place
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Appendix E – Does my patient have an infection?
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Appendix F – Chlorhexidine Bath Cloths

41

Appendix G – Central Line Necessity Tracking Tool
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Appendix H - Central Line Maintenance and Blood Cultures Attestation

43

Appendix I – Hand Hygiene Observation Tool
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Appendix J – Five Moments for Hand Hygiene
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Preferred Vascular Group, Atlanta, GA
Visionary, an accomplished healthcare executive with a valuable combination of business and
clinical experience offering a distinguished career in driving organizational quality, care, and
regulatory compliance. Create positive company culture with a focus on developing high
standards of practice, evaluating patient care for effectiveness, and implementing necessary
changes to programs and policies. Adept at leading teams through metric-driven process
improvement, cost savings, and organizational development initiatives to yield organizationwide satisfaction.
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Executive Director of Operations, May 2011 – January 2015
Preferred Vascular Group, Atlanta, GA
Full-time profit-driven, quality-based turnaround executive with continual profits attained
through focused, strategic workflow, staffing, and business practice analysis. Rapidly secured
gains in diverse leadership roles, identifying areas of maximum ROI, addressing cultural
changes, and tightening cost controls. Full responsibility and accountability for oversight of the
day-to-day operations for nine out-patient ambulatory care facilities throughout the United
States.
Administrator, February 2011 – January 2015
Lifeline Vascular Access, Atlanta, GA
Full-time Administrator that oversaw the operations of multiple out-patient ambulatory surgery
centers with an average patient volume of 3k per year at each location. Responsible for strategic
planning, quality, financials, physician relations, safety, risk management, staffing, equipment
procurement/maintenance, inventory control, and regulatory compliance, including OSHA and
JCAHO. Supervised a staff of over 50. Monitor safety and quality and lead root cause analysis
and healthcare failure & effects mode analysis (HFMEA) activities. Compile and analyze
performance data to identify trends. Administer budgets, perform capital purchasing, and
monitored expenses.
Manager of Cardiovascular Services, February 2008 – 2011
Atlanta Medical Hospital & Medical Center, Atlanta, GA
Full-time Manager of the Cardiac Catheterization Lab, Electrophysiology Lab, ECHO, EKG,
and Cardiac Rehab areas for a 600-bed, Level 1 Trauma Center facility. Developed policies and
procedures for operations, safety, and quality. Supervised a staff of 25 and oversaw hiring and
training. Led the development of new clinical services to increase revenues. Planned and led
quality, I.T., and regulatory initiatives to improve performance. Assessed existing services to
identify areas for improvement. Directed 24x7 nursing functions, including training and
scheduling. Administered a $20M budget and prepared financial and operational performance
reports.
Cardiac Catheterization RN, January 2006 – February 2008
Emory University Hospital Midtown, Atlanta, GA
Full-time R.N. that assisted in directing the daily operations of a six-room cardiac catheterization
lab. Managed patient care, medication, scheduling, staff training, and inventory. Responded to
emergency situations, including myocardial infarctions. Supervised a staff of over forty.
Emergency Department R.N., Surgical ICU & Cardiac Cath RN, June 1996 – 2006
Holmes Regional Hospital & Medical Center, Melbourne, FL
Full-time R.N. that worked ten years in the emergency department, surgical ICU, and cardiac
catheterization departments. Functioned as a team lead in performing assessments, interventions,
and stabilization of critical patients.
LICENSES, CERTIFICATIONS
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•
•
•
•
•
•

Registered Nurse, Nevada (R.N.) – Expires 4/12/2023
Certified Professional in Healthcare Quality (CPHQ) – Expires 5/24/2024
Registered Cardiovascular Invasive Specialist (RCIS) – Expires 12/31/2023
Critical Care Registered Nurse (CCRN) – Expires 6/31/2024
American Nurses Association (NEA-BC) – Expires 2/
LEAN Six Sigma – Yellow Belt

PROFESSIONAL AFFILIATIONS

•
•
•
•
•
•
•
•
•

American College of Healthcare Executives (ACHE) American
Association of Critical-Care Nurses (AACC)
American Nurses Association (ANA)
Nevada Nurses Association (NNA)
Georgia Nurses Association (GNA)
National Association for Healthcare Quality (NAHQ)
Association of Perioperative Registered Nurses (AORN)
Sigma Theta Tau International – Honor Society of Nursing Member
American Organization of Nurse Executives (AONE)
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